FDA Adverse Event Injury Summary report: N

AMPLATZER TORQVUE DELIVERY SYSTEM

MDR report key: 2638360 · Received July 3, 2012

Report

Report Number
2135147-2012-00106
Event Type
Injury
Date Received
July 3, 2012
Date of Event
June 1, 2012
Report Date
June 4, 2012
Manufacturer
AGA MEDICAL CORPORATION
Product Code
DQY
PMA / PMN Number
K120120
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A FOLLOW-UP REPORT WILL BE SUBMITTED UPON COMPLETION OF OUR INVESTIGATION. NOT RETURNED FOR EVALUATION.

Additional Manufacturer Narrative · 1

THE PATIENT'S PRE-IMPLANT MEDICATION REGIMEN WAS ASA MG/D, POST-IMPLANT WAS ASA 100MG/D, CLOPIDOGREL 75MG/D, AND ENOXAPARIN .4ML S.Q. INITIAL MEDWATCH # 2135147-2012-00106 LISTED THE INCORRECT NUMBER, K120120 IS THE CORRECT PMA/510(K) NUMBER. THE DELIVERY SYSTEM ASSOCIATED WITH THIS EVENT WAS NOT RETURNED TO SJM FOR ANALYSIS. DURING MANUFACTURING, THIS DELIVERY SYSTEM LOT UNDERWENT A SERIES OF INSPECTIONS AND TESTS TO CONFIRM PROPER FUNCTION. A REVIEW OF MANUFACTURING DOCUMENTATION CONFIRMED THIS DELIVERY SYSTEM LOT SUCCESSFULLY COMPLETED THESE TESTS. CINE ANGIOGRAPHIC IMAGES RECEIVED BY SJM'S MEDICAL CONSULTANT WERE REVIEWED. THE PATIENT EXPERIENCED A PERICARDIAL EFFUSION POST ACP IMPLANT, BUT THE CAUSE IS UNKNOWN.

Description of Event or Problem · 1

ACCORDING TO THE INFORMATION RECEIVED, AN 18 MM AMPLATZER CARDIAC PLUG (ACP) WAS IMPLANTED USING A 10F AMPLATZER TORQVUE 45X45 DELIVERY SHEATH ((B)(4)). APPROXIMATELY 20 HOURS POST-IMPLANT, A PERFORATION WAS OBSERVED RESULTING IN PERICARDIAL TAMPONADE. NO ACUTE INJURY TO THE LEFT ATRIAL APPENDAGE (LAA) WAS OBSERVED AND THE CAUSE OF THE PERFORATION WAS UNKNOWN. THE PATIENT WAS TAKEN IN FOR SURGERY AND 450ML OF BLOOD WAS ASPIRATED. THE ACP REMAINS IMPLANTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AMPLATZER TORQVUE DELIVERY SYSTEM DELIVERY SYSTEM DQY AGA MEDICAL CORPORATION 9-TV45X45-10F-100 1202067326

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R